20 November 2024
20 November 2024
The UK Health Secretary outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.
The full commercial launch of xvision's CT-Fluoro registration is anticipated in the US market next year.
ŌURA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.
Omron plans to launch its monitors with IntelliSense AFib in the US market in early 2025.
Illumina plans for the global rollout of TruSight Oncology 500 v2, a new version of its NGS cancer assay, by mid-2025.
The trial was conducted at Vanderbilt University Medical Center by co-lead investigators Nicholas Kavoussi and Ryan Hsi.
LogicMark claims that Freedom Alert Max is the first device on the market to feature emergency video for caregivers.
The high cost of advanced EP diagnostic catheters could hinder accessibility, particularly in cost-sensitive healthcare settings.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
